PBM Stock Analysis: Buy, Sell, or Hold?
PBM - Psyence Biomedical Ltd. Common Shares
$4.20
-0.13 (-3.05%)
▼
5d:
+16.29%
30d:
+42.31%
90d:
+2.39%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Sep 28, 2026
Get Alerted When PBM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PBM shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PBM shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PBM is currently trading at $4.20, which is considered extended relative to its 30-day fair value range of $2.97 to $3.83.
Technical Outlook: Technically, PBM is in a downtrend. Immediate support is located at $3.22, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: PBM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PBM is in a downtrend. Immediate support is located at $3.22, while resistance sits at $5.00. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: PBM scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.97 -
$3.83
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
5.9%
All Signals
- BEARISH: Price extended above range (+9.6% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.97 -
$3.83
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.22
Resistance Level
$5.00
Current Trend
Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 24, 2026 2:34 PM ET
Data refreshes hourly during market hours. Next update: 3:34 PM
Data refreshes hourly during market hours. Next update: 3:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PBM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 62 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 47 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 43 HOLD |
|
EYPT
EyePoint, Inc |
STRONG BUY
13 analysts |
$27 | 49 HOLD |
